Ces informations sont à titre éducatif uniquement. Elles ne constituent pas un avis médical. Consultez toujours un professionnel de santé qualifié.
Description, Posologie, Effets secondaires, Contre-indications. Data from EMA, URPL, openFDA and other regulatory sources.
| Metronidazole | Clindamycin | |
|---|---|---|
| Substances actives | METRONIDAZOLE | CLINDAMYCIN PHOSPHATE |
| Code ATC | A01AB17 | D10AF01 |
| Forme | CAPSULE | INJECTION, SOLUTION |
| Posologie | 375MG | 150 mg/mL |
| Voie d'administration | ORAL | INTRAVENOUS |
| Fabricant | PFIZER INC | Medical Purchasing Solutions, LLC |
Metronidazole (INN: METRONIDAZOLE, ATC A01AB17) and Clindamycin (INN: CLINDAMYCIN PHOSPHATE, ATC D10AF01) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
Ces informations sont à titre éducatif uniquement. Elles ne constituent pas un avis médical. Consultez toujours un professionnel de santé qualifié.